Here, using several methods, we demonstrate that melanoma cells with knockdown of sirtuin 2 (SIRT2) are more susceptible to cisplatin, suggesting that this sirtuin might be involved in the mechanisms of melanoma resistance to this drug [21]. The gene discussed is SIRT2; the disease is melanoma.